A molecular mechanism to diversify Ca<sup>2+</sup> signaling downstream of Gs protein-coupled receptors.

Brands, Julian; Bravo, Sergi; Jürgenliemke, Lars; Grätz, Lukas; Schihada, Hannes; Frechen, Fabian; Alenfelder, Judith; Pfeil, Cy et al. · Nat Commun · 2024

basic_science · Level V

Where this comes from

Abstract

A long-held tenet in inositol-lipid signaling is that cleavage of membrane phosphoinositides by phospholipase Cβ (PLCβ) isozymes to increase cytosolic Ca<sup>2+</sup> in living cells is exclusive to Gq- and Gi-sensitive G protein-coupled receptors (GPCRs). Here we extend this central tenet and show that Gs-GPCRs also partake in inositol-lipid signaling and thereby increase cytosolic Ca<sup>2+</sup>. By combining CRISPR/Cas9 genome editing to delete Gα<sub>s</sub>, the adenylyl cyclase isoforms 3 and 6, or the PLCβ1-4 isozymes, with pharmacological and genetic inhibition of Gq and G11, we pin down Gs-derived Gβγ as driver of a PLCβ2/3-mediated cytosolic Ca<sup>2+</sup> release module. This module does not require but crosstalks with Gα<sub>s</sub>-dependent cAMP, demands Gα<sub>q</sub> to release PLCβ3 autoinhibition, but becomes Gq-independent with mutational disruption of the PLCβ3 autoinhibited state. Our findings uncover the key steps of a previously unappreciated mechanism utilized by mammalian cells to finetune their calcium signaling regulation through Gs-GPCRs.

Medical subject headings